Abstract: Nucleic acids encoding C1 inhibitor are described. Also described are expression cassettes, vectors, cells, and cell lines containing the nucleic acids, as well as methods of using the nucleic acids to treat complement-mediated disorders, such as hereditary angioedema.

Abstract: Disclosed is an ECG sensor having a packaging label form factor. The ECG sensor may comprise a set of electrodes configured to sense heart-related electrical activity when in contact with skin of a user and produce electrocardiogram (ECG) waveforms representing the sensed heart-related electrical activity. The ECG sensor may further comprise a processor configured to: identify, using a machine learning model, the user based on the ECG waveforms, convert the ECG waveforms to a modulated signal that carries the ECG waveforms representing the sensed heart-related electrical activity, and transmit the modulated signal wirelessly to a computing device using a transmitter. The ECG sensor may also comprise a housing having a first layer and a second layer, wherein the set of electrodes, the processor, and the transmitter are all disposed between the first layer and the second layer of the housing, and wherein the housing has a packaging-label form factor.

Abstract: Embodiments of the present disclosure provide a monitoring device that combines blood pressure, SpO2, and ECG monitoring functionality into a single handheld device and can measure these parameters simultaneously. The monitoring device may comprise a first sensor comprising an electrode to measure electrical signals corresponding to cardiac activity of a user's heart and a second sensor comprising an electrode as well as an optical sensor to perform a PPG and measure an amount of light absorbed by the blood of the user concurrently with measurement of the electrical signals. The optical sensor may generate a blood pressure signal and an oxygen saturation signal based at least in part on the amount of light absorbed by the blood of the user. The optical sensor may include a neural network trained to estimate blood pressure based on PPG measurements and demographic information of the user, as discussed in further detail herein.

Abstract: Disclosed systems include mobile ECG sensors, systems and methods. Some embodiments provide ECG sensors in a packaging-label form factor that allows a user to contact two electrically isolated electrodes on an exterior of a product packaging to measure heart electrical signals for a Lead I ECG.

Abstract: Described herein is an apparatus for monitoring various physiological parameters of a user. The apparatus may include a housing with a small or reduced form factor near the size of a credit or debit card, so as to allow a user to obtain e.g., an electrocardiogram (ECG) measurement from various locations. The apparatus may include an electrode assembly comprising a set of electrodes disposed on the housing to perform an ECG by sensing an electrical signal corresponding to heart activity of a user when in contact with skin of the user and output the electrical signal. The apparatus may detect or generate six or more ECG leads.

Abstract: Embodiments of the present disclosure provide a 6-lead electrocardiogram (ECG) monitoring device that may acquire a 6-lead ECG, does not require the use of adhesives for electrodes, provides ECG data for a user on a near instantaneous basis, and provides an easy and non-invasive way for a user to take a 6-lead ECG on the fly. The ECG monitoring device may acquire leads I, II, and III. The ECG monitoring device may derive augmented limb leads to generate a 6-lead ECG and may subsequently generate a full 12-lead ECG. The ECG monitoring device may generate one or more diagnoses based on the 6-lead reading or the 12-lead set.

Abstract: Provided according to embodiments of the invention are methods of monitoring the direction of blood flow that include processing with a computer photoplethysmography (PPG) signal streams from a sensor array on a body site of the individual to determine the direction and/or velocity of the blood flow at the body site of the individual. In some embodiments, direction of the blood flow at the body site is determined by the phase difference between at least three PPG signal streams from the sensor array, wherein the at least three PPG signal streams are generated from emissions of the at least three emitters.

Abstract: Embodiments of the present disclosure relate to determining an optimal location on the body of a person where heart sounds may be optimally heard. The optimal location may be determined at a time prior to the attempted auscultation and ECG data corresponding to the optimal location may be stored in a memory of an auscultation device. Subsequently, when a e.g., physician wishes to listen to the heart sounds of the person, the physician may place the auscultation device at a first location on the patient. The auscultation device may periodically perform an ECG at a current location and use the ECG data at the current location and the ECG data at the optimal location to determine and provide guidance to the physician regarding a direction in which the auscultation device should be moved in order to reach the optimal location.

Abstract: Disclosed systems include mobile ECG sensors, systems and methods. Some embodiments provide ECG sensors in a packaging-label form factor that allows a user to contact two electrically isolated electrodes on an exterior of a product packaging to measure heart electrical signals for a Lead I ECG.

Abstract: Embodiments of the present disclosure are directed to an electrocardiogram (ECG) monitoring device embedded into the construct of a controller (e.g., video game controller, steering wheel etc.) to monitor a user's heart health and diagnose various conditions (e.g., AFib, tachycardia, bradycardia, etc.). The controller may comprise a set of electrodes including electrodes to contact the user's hands and one or more electrodes on the back of the controller that can be used to contact the user's extremities as a 3rd contact point to provide additional leads for higher accuracy ECG sensing. The set of electrodes may be positioned at locations on the controller where the user's hands are relatively stable, thus minimizing motion artifacts caused by muscular movement (thereby allowing for signal stability and longevity).

Abstract: Provided according to embodiments of the invention are methods of monitoring the direction of blood flow that include processing with a computer photoplethysmography (PPG) signal streams from a sensor array on a body site of the individual to determine the direction and/or velocity of the blood flow at the body site of the individual. In some embodiments, direction of the blood flow at the body site is determined by the phase difference between at least three PPG signal streams from the sensor array, wherein the at least three PPG signal streams are generated from emissions of the at least three emitters.

Abstract: The present invention relates to systems and methods for comparing photoplethysmography (PPG) signals from an individual with signals from a secondary respiration sensor secured to the individual to determine whether effective respiration has occurred or whether the individual has apnea, hypopnea, or other respiratory distress.

Abstract: Provided according to embodiments of the invention are methods of monitoring the direction of blood flow that include processing with a computer photoplethysmography (PPG) signal streams from a sensor array on a body site of the individual to determine the direction and/or velocity of the blood flow at the body site of the individual. In some embodiments, direction of the blood flow at the body site is determined by the phase difference between at least three PPG signal streams from the sensor array, wherein the at least three PPG signal streams are generated from emissions of the at least three emitters.

Abstract: Provided according to embodiments of the invention are systems for monitoring a physiological state of an individual that include a PPG sensor, which optionally includes an auxiliary physiological sensor integrated with or connected thereto; a first signal processing device in electronic communication with the PPG sensor, whereby the PPG sensor transmits PPG signals to the first signal processing device; and a second signal processing device that detects at least a portion of the signals transmitted by the PPG sensor to the first signal processing device, at least a portion of signals transmitted by the auxiliary physiological sensor, or both. Related methods are also provided herein.

Abstract: Provided herein are methods and systems for validating and interpreting respiratory signals in order to provide comprehensive non-invasive methods to monitor patients at risk for respiratory depression and apnea. In the present invention, data from multiple respiratory monitoring technologies (or from multiple channels of one monitoring technology) is fused so that the patient's true respiratory state may be elucidated.

Abstract: The present invention relates to systems and methods for comparing photoplethysmography (PPG) signals from an individual with signals from a secondary respiration sensor secured to the individual to determine whether effective respiration has occurred or whether the individual has apnea, hypopnea, or other respiratory distress.

Abstract: Provided according to embodiments of the present invention are multiparameter monitors that include a primary screen that displays signals or parameters provided by at least one parameter module; and a parameter module that includes a detachable processing device.

Abstract: Provided according to embodiments of the invention are methods of monitoring the direction of blood flow that include processing with a computer photoplethysmography (PPG) signal streams from a sensor array on a body site of the individual to determine the direction and/or velocity of the blood flow at the body site of the individual. In some embodiments, direction of the blood flow at the body site is determined by the phase difference between at least three PPG signal streams from the sensor array, wherein the at least three PPG signal streams are generated from emissions of the at least three emitters.

Abstract: Provided herein are methods and systems for validating and interpreting respiratory signals in order to provide comprehensive non-invasive methods to monitor patients at risk for respiratory depression and apnea. In the present invention, data from multiple respiratory monitoring technologies (or from multiple channels of one monitoring technology) is fused so that the patient's true respiratory state may be elucidated.

Abstract: Provided according to embodiments of the invention are systems for monitoring a physiological state of an individual that include a PPG sensor, which optionally includes an auxiliary physiological sensor integrated with or connected thereto; a first signal processing device in electronic communication with the PPG sensor, whereby the PPG sensor transmits PPG signals to the first signal processing device; and a second signal processing device that detects at least a portion of the signals transmitted by the PPG sensor to the first signal processing device, at least a portion of signals transmitted by the auxiliary physiological sensor, or both. Related methods are also provided herein.